Literature DB >> 3710191

Ciclosporin concentration in the rabbit aqueous humor and cornea following subconjunctival administration. Importance of anatomical site of injection.

W Behrens-Baumann, S Theuring, B Frey, F Frey, H Sostmann, J Bircher.   

Abstract

The model compound lidocaine was used in the rabbit to investigate different sites of subconjunctival injection for the achievement of reproducible drug concentrations in the aqueous humor. Only epibulbar injections were satisfactory, but not parabulbar or injections under the lower fornix. After epibulbar administration of 0.8 ml 5% ciclosporin, median concentrations in the aqueous humor were 360, 700 and 200 ng/ml after 2, 8, and 24 h, respectively. Corresponding levels in the cornea were 32, 27, and 12 ng/ml. It appears that drug concentrations resulting from epibulbar injections may be therapeutically useful.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710191     DOI: 10.1007/bf02150031

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  14 in total

1.  Subepithelial versus subcapsular injections of drugs.

Authors:  K C SWAN; H R CRISMAN; P F BAILEY
Journal:  AMA Arch Ophthalmol       Date:  1956-07

2.  Ocular penetration of 14C-labeled chloramphenicol following subconjunctival or sub-Tenon's injection.

Authors:  R G Hardy; C A Paterson
Journal:  Am J Ophthalmol       Date:  1971-06       Impact factor: 5.258

Review 3.  Cyclosporine: experience with therapeutic monitoring.

Authors:  L D Bowers; D M Canafax
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

4.  Prolonged corneal graft survival using topically applied cyclosporin A.

Authors:  P A Hunter; N S Rice; B R Jones
Journal:  Trans Ophthalmol Soc U K       Date:  1982-04

5.  A placebo-controlled blind trial of cyclosporin-A in prevention of corneal graft rejection in rabbits.

Authors:  T A Bell; D L Easty; K G McCullagh
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

6.  Corneal graft rejection: a new rabbit model and cyclosporin-A.

Authors:  P A Hunter; A Garner; K R Wilhelmus; N S Rice; B R Jones
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

7.  Suppression of corneal allograft rejection by cyclosporin A.

Authors:  J D Salisbury; B M Gebhardt
Journal:  Arch Ophthalmol       Date:  1981-09

8.  A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

Authors:  P Donatsch; E Abisch; M Homberger; R Traber; M Trapp; R Voges
Journal:  J Immunoassay       Date:  1981

9.  Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

Authors:  P A Hunter; K R Wilhelmus; N S Rice; B R Jones
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Effect of cyclosporin A on the survival of corneal grafts in rabbits.

Authors:  W F Shepherd; D J Coster; T C Fook; N S Rice; B R Jones
Journal:  Br J Ophthalmol       Date:  1980-03       Impact factor: 4.638

View more
  4 in total

1.  Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration.

Authors:  W Behrens-Baumann; J Martell
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Topical treatment of severe corneal ulcers with cyclosporin A.

Authors:  M Zierhut; H J Thiel; E G Weidle; R Waetjen; U Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

4.  The effect of topical cyclosporin A on the rabbit cornea. A clinical and electron microscopic study.

Authors:  W Behrens-Baumann; S Theuring; H Brewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.